跳至主要内容
临床试验/NCT07186088
NCT07186088尚未招募不适用

Study on the Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies for Adult Myopia Treatment

Ruihua Wei1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年9月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Axial length

研究概览

简要总结

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light

详细描述

The experiment will be divided into two phases. In the first phase, the subjects will be randomly grouped using laser equipment and LED equipment, and each group will be exposed to the red light twice a day for one month. The second stage involves self-comparison of the laser equipment, with the usage frequencies being once a day and three times a day.

To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light in different devices and frequencies, as well as its impact on the axial length, spherical equivalent refraction and choroidal thickness of myopia progression.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18-35 years old, gender not limited; Obtained informed consent.

排除标准

  • •Obvious strabismus and amblyopia
  • •With congenital eye disease, such as congenital cataract, congenital retinal disease
  • •Secondary myopia (such as premature retinopathy or other eye diseases in infants and children caused secondary myopia), or myopia combined with systemic syndrome (such as Marfan syndrome)
  • •Had internal eye surgery (such as cataract extraction, intraocular lens implantation, anti-glaucoma surgery, etc.)
  • •Refractive medium opacity (such as corneal disease, crystal opacity, etc.)
  • •Bnormal intraocular pressure and clinical significance (IOP <10 mmHg or IOP>21mmHg or binocular IOP difference ≥5mmHg)
  • •Fundus chorioretinopathy (except for high myopia fundus degenerative changes) or other intraocular diseases
  • •Optic nerve damage or congenital optic nerve dysfunction
  • •Can not be regularly checked
  • •The adjustment range is less than 8D or obvious near difficulties
  • •Other reasons researchers think it is not suitable for inclusion in researchers

研究组 & 干预措施

The Laser Group

Experimental

Use Eyerising (RS-200-2A), 1 time,2 times or 3 times a day

干预措施: Eyerising RS-200-2A (Device)

The LED Group

Experimental

Use Airdoc (Sky-n1201), 2 times a day

干预措施: Airdoc Sky-n1201 (Device)

结局指标

主要结局

Axial length

时间窗: From enrollment to the end of treatment up to 7 months

次要结局

  • Spherical equivalent(From enrollment to the end of treatment up to 7 months)
  • Choroidal thickness(From enrollment to the end of treatment up to 7 months)

研究者

发起方
Ruihua Wei
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ruihua Wei

Professor

Tianjin Medical University Eye Hospital

研究点 (1)

Loading locations...

相似试验